Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 2.68 is 134% above its 5-year average of -7.90, near the high end of its 5-year range (-14.55–2.68).
294.39% above its 12-month average of -1.38.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.08.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:12:01.637Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
2.68
EARNINGS PER SHARE (EPS) AVG TTM
-1.38
EARNINGS PER SHARE (EPS) AVG 3Y
-6.44
EARNINGS PER SHARE (EPS) AVG 5Y
-7.90
EARNINGS PER SHARE (EPS) AVG 10Y
-13.70
EARNINGS PER SHARE (EPS) AVG 15Y
-12.69
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+294.39%
CURRENT VS 3Y AVG
+141.59%
CURRENT VS 5Y AVG
+133.94%
CURRENT VS 10Y AVG
+119.56%
CURRENT VS 15Y AVG
+121.13%
CURRENT VS 20Y AVG
N/A
Fortress Biotech, Inc.
Market Cap
$68.43M
Earnings Per Share (EPS)
2.68
TTM Avg
-1.38
3Y Avg
-6.44
5Y Avg
-7.90
Market Cap
$68.08M
Earnings Per Share (EPS)
-0.08
TTM Avg
0.13
3Y Avg
-0.17
5Y Avg
-0.10
Market Cap
$65.73M
Earnings Per Share (EPS)
-5.01
TTM Avg
-7.16
3Y Avg
-89.38
5Y Avg
-71.00
Market Cap
$70.12M
Earnings Per Share (EPS)
-0.33
TTM Avg
-1.03
3Y Avg
-28.69
5Y Avg
-510.63
Market Cap
$70.01M
Earnings Per Share (EPS)
-0.26
TTM Avg
-0.44
3Y Avg
-0.60
5Y Avg
-0.58
Market Cap
$65.81M
Earnings Per Share (EPS)
-55.66
TTM Avg
-39.81
3Y Avg
-97.72
5Y Avg
-154.19
Market Cap
$65.11M
Earnings Per Share (EPS)
-0.19
TTM Avg
-0.10
3Y Avg
-0.67
5Y Avg
-1.24
Market Cap
$64.68M
Earnings Per Share (EPS)
-1.09
TTM Avg
-1.47
3Y Avg
-0.85
5Y Avg
-0.92
Market Cap
$63.30M
Earnings Per Share (EPS)
-2.02
TTM Avg
-7.29
3Y Avg
-26.82
5Y Avg
-38.33
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | $68.43M | 2.68 | -1.38 | -6.44 | -7.90 |
| Champions Oncology, Inc. (CSBR)vs › | $68.08M | -0.08 | 0.13 | -0.17 | -0.10 |
| Cingulate Inc. (CING)vs › | $65.73M | -5.01 | -7.16 | -89.38 | -71.00 |
| iBio, Inc. (IBIO)vs › | $70.12M | -0.33 | -1.03 | -28.69 | -510.63 |
| MindWalk Holdings Corp. (HYFT)vs › | $70.01M | -0.26 | -0.44 | -0.60 | -0.58 |
| Gossamer Bio, Inc. (GOSS)vs › | $65.81M | -55.66 | -39.81 | -97.72 | -154.19 |
| Heron Therapeutics, Inc. (HRTX)vs › | $65.11M | -0.19 | -0.10 | -0.67 | -1.24 |
| InterCure Ltd. (INCR)vs › | $64.68M | -1.09 | -1.47 | -0.85 | -0.92 |
| Kalaris Therapeutics Inc (KLRS)vs › | $63.30M | -2.02 | -7.29 | -26.82 | -38.33 |
| Alps Group Inc (ALPS)vs › | $63.23M | N/A | -0.02 | -0.02 | -0.01 |
Trailing EPS (TTM)
$2.68
Forward EPS (Est.)
$2.55
P/E Ratio
0.8
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.07 |
| 2024-12-31 | -2.69 |
| 2023-12-31 | -8.47 |
| 2022-12-31 | -14.55 |
| 2021-12-31 | -11.85 |
| 2020-12-31 | -9.75 |
| 2019-12-31 | -10.95 |
| 2018-12-31 | -29.04 |
| 2017-12-31 | -24.08 |
| 2016-12-31 | -20.68 |
| 2015-12-31 | -18.56 |
| 2014-12-31 | -8.42 |
| 2013-12-31 | -18.32 |
| 2012-12-31 | -19.12 |
| 2011-12-31 | -4.74 |
| 2010-12-31 | -1.69 |
| 2009-12-31 | -15.15 |
| 2008-12-31 | -20.85 |
